At least one report demonstrated that patients with melanoma brain metastases treated with combination BRAF inhibitor and stereotactic radiotherapy experienced greater rates of intra-tumoral hemorrhage when compared to radiotherapy alone (84). The gene discussed is BRAF; the disease is melanoma.